Objective: Ultrasonography and cytology obtained by fine-needle aspiration are part of the basic study of the thyroid nodule. Although they are not diagnostic in every case, they are cost-effective methods that inform surgical treatment and its extent.
| INTRODUC TI ON
The incidence of thyroid nodules is high, with a reported prevalence of 19%-68% in the unselected population. 1, 2 They are frequently asymptomatic, and their study is important because of the risk of associated malignancy in 7%-15% of cases. 3 Cervical ultrasound (US) is the first-line imaging study, recommended to determine the need for a cytological study. 4 Its usefulness in thyroid pathology is widely accepted. Ultrasound-guided fine-needle aspiration (FNA) is a minimally invasive procedure that provides valuable clinical and pathological information for ordering specimens according to the Bethesda classification. 5 The combination of both diagnostic tests represents the optimal diagnostic approach in most cases.
The main objective of this study was to ascertain the relationship between ultrasound features and cytopathology to predict malignancy of a thyroid nodule. A secondary objective was to study whether the accuracy of diagnostic tests is similar in patients with a single nodule and with multinodular goitre (MNG).
| MATERIAL S AND ME THODS
Data from patients who underwent thyroidectomy at a single tertiary hospital and who had been studied preoperatively through thy- According to ultrasound characteristics, patients were classified into 2 different groups. "Benign ultrasound" if they had 1 or no malignant features; "Suspicious ultrasound" when they had 2 or more malignant features. In terms of statistical analysis, qualitative variables were expressed in absolute numbers and percentages. For each ultrasound criteria of malignancy studied, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were determined. The ability of each ultrasound characteristic to detect malignancy was determined.
The association between the presence or absence of ultrasound features and the result of the surgical specimen was evaluated through contingency tables using chi-square tests. An alpha risk of 5% and a 95% confidence interval were used as limit of statistical significance in all cases.
Concordance of ultrasound was evaluated through the kappa test, using anatomical pathology as a reference method and a con- 
| RE SULTS
A total of 492 patients were evaluated. Of these, 75 were ex- presented carcinoma in the definitive study. Overall, US had a sensitivity of 32%, specificity of 93%, PPV of 73% and NPV of 67%.
The majority of patients (n = 186, 45%) had Bethesda II cytology.
The relationship between cytology, US and percentage of malignancy is shown in patients (14%) who had suspicious ultrasound, 18 (62%) were diagnosed with carcinoma in the pathology study ( Table 3 ).
The sensitivity of the US study in patients with single nodule was 10% higher than in patients with MNG (36% vs 26%), with a specificity of 92% in both cases. The positive and negative predictive values for single nodule cases were of 81% and 63%, respectively, compared to 62% and 71% in MNG. There was a statistically significant difference (P = .001) between the percentage of malignancy in single nodule and MNG patients (46% vs 33%).
As for the detailed study of the US characteristics, hypoechogenicity was present in 31.5% of cases, 57% of which were malignant.
The presence of hypoechogenicity showed high sensitivity (89%) but a low specificity (46%) to detect malignant thyroid nodules.
Microcalcifications were present in 26% of the studied cases, 57% of which were malignant. This was a highly specific US feature (82%) that showed poor sensitivity (39%).
Increased thyroid nodule central vascularity was present in 13% of cases, 56% of which were malignant. This feature had moderate sensitivity (65%) and specificity (56%).
The absence of a halo was observed in <1% of patients and was not described in 96% of the cases. Irregular margins were present in 6% of cases, 54% of which were malignant and were not described in 88% of cases. Due to the high rate of thyroid nodules for which the presence or absence of a halo and irregular margins were not described, its diagnostic accuracy can hardly be assessed. Most US reports described the dimensions of the nodules without clearly specifying what each measurement represented. Thus, the "taller than wider" US characteristic was excluded from the study.
The general concordance level of malignant nodules was weak for the following criteria: hypoechogenicity (K = 0.33, P < .001), presence of microcalcifications (K = 0.22, P < .001) and increased vascularization (K = 0.20, P = .04). Concordance results were not statistically significant with respect to other features (Table 4) .
Hypoechogenicity, microcalcifications and irregular margins are more frequently observed in thyroid nodules classified as Bethesda V and VI, as shown in Figure 1 .
| D ISCUSS I ON
The incidence of thyroid nodules is high. 1, 2 In Spain, approximately 4% of the general population will present with a thyroid nodule 7 and it has been reported that 7% to 15% of cases may be malignant. 11 the American Association of Clinical Endocrinologist criteria has a higher specificity but lower sensitivity (94% and 74%, respectively), 12 and the Kim criteria provides greater sensitivity (93%) with a specificity of 81%. 13 Nevertheless, the criteria used by Society of Radiologist in Ultrasound is based on the size of the nodules and is less precise in the detection of malignancy. 14 In conclusion, ultrasoundbased reporting systems provide better management of patients while being cost-effective and reducing unnecessary FNA. 15 It should be noted that, when reviewing radiology reports, certain US characteristics of malignancy were not mentioned. This raises the question of whether these were present and not mentioned or if they
were not directly observed. Thus, it is important to call for more comprehensive reports on the characteristics of thyroid nodules.
Regarding FNA results, certain differences are observed as compared to data published by other authors. Specifically, in the Bethesda I and IV groups, our results show, respectively, 48% and 63% of malignancy, whereas a meta-analysis of 8 studies by Bongiovanni et al 16 reported a range of malignancy of between 9% and 32% for Bethesda I and between 14% and 34% for Bethesda IV. This difference in outcomes was attributed to the higher prevalence of malignancy in our series, likely caused by the greater complexity of our patient population and higher rate of offsite referral for low risk of malignancy cases.
However, it is important to highlight the Bethesda II group, theoretically benign, 16 where 38% of cases with suspicious US were found to have cancer, compared to 10% of those with nonsuspect US.
Moreover, in patients with undetermined Bethesda (III), suspicious US resulted in 12% more malignancies detected. The combination of US characteristics and FNA findings results in an increase in diagnostic accuracy.
We decided to separately analyse patients with a single thyroid nodule and patients with MNG to establish possible differences in the diagnostic accuracy of US and FNA. Both diagnoses add up to approximately 50% of the sample size.
We observed a significant difference (P = .001) in the malignancy rate in patients with MNG (33%) as compared to those with a single nodule (46%). It has traditionally been considered that thyroid nodules found in the context of MNG are less likely to present carcinoma, but recent studies report conflicting results. In a metaanalysis by Brito et al 17 patients with MNG were found to be less likely to present cancer when compared to patients who had single thyroid nodules. Frates et al 18 described that the probability of cancer is independent of the number of nodules, but the probability of cancer in a nodule decreases as the number of nodules increases.
Other studies report a similar incidence of malignant disease in patients with MNG and single nodule. 19, 20 Hypoechogenicity has been described as 1 of the most important ultrasound criteria associated with thyroid cancer. In this study, it was observed predominantly in malignant nodules (Bethesda VI, 40% observed) or in those suspicious for malignancy (Bethesda V, 44% observed). It was also observed in 50% of follicular neoplasms (Bethesda IV), 30% AUS/FLUS (Bethesda III) and 25% of benign cytologies (Bethesda II). Both the sensitivity (89%) and the specificity (46%) of hypoechogenicity are comparable with those of previous studies (27%-87% and 43%-94%, respectively).
9,21
Hypoechogenicity has a weak (K = 0.33, P < .001) concordance with malignant neoplasia, but is not by itself diagnostic for malignant thyroid nodule.
The presence of microcalcifications is similar in the different nodule groups: malignant (Bethesda VI, 44% presence), suspicious (Bethesda V, 40% presence) and undetermined (Bethesda I, 37% presence). They are also present in 20% of benign nodules (Bethesda II). The sensitivity (39%) and specificity (82%) of this criterion are lower compared with previous studies (S 60% and E 98%). 22 Unlike the findings in other studies, microcalcifications show statistically significant differences and a slight (K = 0.22, P < 0.001) concordance with malignant neoplasia. 20 Increased nodule vascularity was greater in malignant (Bethesda VI, 22% presence), suspicious (Bethesda V, 21% presence) and undetermined (Bethesda I, 21% presence) nodules and less frequent in benign (Bethesda II, 10%) nodules. This US characteristic showed a sensitivity similar to that of previous studies (S 65% vs 54%-74%), but a lower specificity (E 56% vs 79%-81%). 22 This feature alone has a weak (K = 0.20, P = .04) concordance with malignancy.
In a recent meta-analysis by Brito et al 10 that studies US characteristics of malignancy, it was determined that intranodular calcifications had a sensitivity of 54% and a specificity of 81%;
Hypoechogenicity had a sensitivity of 73% and a specificity of 56%;
And increased intranodular flow had a sensitivity of 48% and a specificity of 56%.
In general, all US malignancy characteristics are shown to increase as the grade of the Bethesda classification increases, disregarding Bethesda I (nondiagnostic cytologies) (Figure 1 ).
This study has some limitations. It is retrospective cohort study, carried out in a single oncological tertiary centre and over an extended period of time (10 years).
In conclusion, thyroid cytology is highly predictive of thyroid carcinoma. The predictive value of US is also high, mainly in the study of 
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